Medscape: Oral Anticoagulants Trump Antiplatelet Therapy for Primary Stroke Prevention In Nonvalvular AF Oral Anticoagulants Trump Antiplatelet Therapy for Primary Stroke Prevention In Nonvalvular AF Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and coronary ... EurekAlert!: Oral anticoagulants plus antiplatelets associated with poor outcome in atrial fibrillation Munich, Germany - 28 Aug 2018: Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients ...

Understanding the Context

News Medical: Combined oral anticoagulant and antiplatelet therapy linked to poor prognosis in atrial fibrillation Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ... Combined oral anticoagulant and antiplatelet therapy linked to poor prognosis in atrial fibrillation Please provide your email address to receive an email when new articles are posted on . Patients who receive antiplatelet or anticoagulant therapy appear to experience gross hematuria earlier than ... Patients with newly diagnosed atrial fibrillation who take not only an oral anticoagulant (OAC) but also an antiplatelet face increased risks of stroke and bleeding at 1 year, according to an analysis ...

Key Insights